{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:29:57Z","timestamp":1790508597329,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001592","name":"Higher Education Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023699","name":"Health Data Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cancer Policy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jcpo.2026.100708","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T15:47:22Z","timestamp":1768751242000},"page":"100708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Analysis and recommendations to improve national cancer control plans and policies informed by a 20 country analysis"],"prefix":"10.1016","volume":"47","author":[{"given":"Mark","family":"Lawler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba L.","family":"Degi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Thurston-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcpo.2026.100708_bib1","series-title":"Global Cancer Burden Growing, amidst Mounting Need for Services","author":"IARC","year":"2024"},{"issue":"4","key":"10.1016\/j.jcpo.2026.100708_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","article-title":"Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050","volume":"9","author":"Chen","year":"2023","journal-title":"JAMA Oncol."},{"issue":"10","key":"10.1016\/j.jcpo.2026.100708_bib3","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1016\/S1470-2045(18)30681-8","article-title":"National cancer control plans: a global analysis","volume":"19","author":"Romero","year":"2018","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.jcpo.2026.100708_bib4","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1016\/S1470-2045(22)00450-8","article-title":"Exploring the link between cancer policies and cancer survival: a comparison of international cancer benchmarking partnership countries","volume":"23","author":"Nolte","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcpo.2026.100708_bib5","series-title":"Why Every Country Needs A Strong National Cancer Control Plan","author":"Dando","year":"2025"},{"key":"10.1016\/j.jcpo.2026.100708_bib6","unstructured":"National Cancer Control Programmes: Policies and Managerial Guidelines, The Health Organization, 2002."},{"key":"10.1016\/j.jcpo.2026.100708_bib7","unstructured":"Controlling cancer, WHO, n.d. \u3008https:\/\/www.who.int\/activities\/controlling-cancer\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib8","unstructured":"Europe\u2019s Beating Cancer Plan Communication from the commission to the European Parliament and the Council, n.d. \u3008https:\/\/health.ec.europa.eu\/system\/files\/2022-02\/eu_cancer-plan_en_0.pdf\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib9","series-title":"NCCP Review 2\u2011pager","author":"Union for International Cancer Control","year":"2018"},{"issue":"1","key":"10.1016\/j.jcpo.2026.100708_bib10","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/S1470-2045(24)00405-4","article-title":"The changing global landscape of national cancer control plans","volume":"26","author":"Romero","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcpo.2026.100708_bib11","unstructured":"International Cancer Control Partnership, n.d. What makes a good National Cancer Control Plan? \u3008Https:\/\/Www.Iccp-Portal.Org\/Developing-Nccp#:\u223c:Text=A%20number%20of%20elements%20are%20central%20to%20developing,Support%20a%20country%E2%80%99s%20cancer%20control%20efforts.%20More%20items\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib12","series-title":"Plan directeur 2025 pour les soins en Suisse en mati\u00e8re de cancer","author":"Oncosuisse","year":"2024"},{"key":"10.1016\/j.jcpo.2026.100708_bib13","series-title":"An Evidence-Based Framework to Determine Funding Requirements for NCCPs","author":"Wilsdon","year":"2025"},{"key":"10.1016\/j.jcpo.2026.100708_bib14","series-title":"Review of Europe\u2019s Beating Cancer Plan","author":"European Commission","year":"2025"},{"issue":"1","key":"10.1016\/j.jcpo.2026.100708_bib15","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S1470-2045(23)00511-9","article-title":"The future of cancer care in the UK\u2014time for a radical and sustainable National Cancer Plan","volume":"25","author":"Aggarwal","year":"2024","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.jcpo.2026.100708_bib16","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S1470-2045(24)00448-0","article-title":"The UK needs to be a leader, not a lagger, in the global cancer effort","volume":"25","author":"Lawler","year":"2024","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100708_bib17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1470-2045(25)00033-6","article-title":"UK's national cancer plan needs to be radical, accountable, and deliverable","volume":"26","author":"Lawler","year":"2025","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.jcpo.2026.100708_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1470-2045(25)00202-5","article-title":"Living within our means: trouble ahead for England's cancer planning","volume":"26","author":"Lawler","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcpo.2026.100708_bib19","unstructured":"National Cancer Control Plan Development and Implementation Assessment Tool, 2016. \u3008https:\/\/www.iccp-portal.org\/resources\/national-cancer-control-plan-development-and-implementation-assessment-tool\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib20","series-title":"China Initiates Action Plan to Raise Cancer Survival Rate","author":"Xinhua","year":"2023"},{"key":"10.1016\/j.jcpo.2026.100708_bib21","series-title":"T\u00fcrkiye National Cancer Control Programme (NCCP 18 April 2022)","author":"Ministry of Health","year":"2022"},{"key":"10.1016\/j.jcpo.2026.100708_bib22","doi-asserted-by":"crossref","unstructured":"EU Country Cancer Profile: Germany 2025, OECD, 2023. \u3008https:\/\/doi.org\/10.1787\/f3a3cfcf-en\u3009 (last accessed 28th October 2025).","DOI":"10.1787\/f3a3cfcf-en"},{"key":"10.1016\/j.jcpo.2026.100708_bib23","series-title":"Per Capita Consumption of Cigarettes","author":"Statistisches Bundesamt (Destatis)","year":"2022"},{"key":"10.1016\/j.jcpo.2026.100708_bib24","series-title":"Reducing Social Inequalities in Cancer: Evidence and Priorities for Research","article-title":"Social inequalities in cancer risk factors and health-care access","author":"Denny","year":"2019"},{"issue":"3","key":"10.1016\/j.jcpo.2026.100708_bib25","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/S2214-109X(17)30058-X","article-title":"Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: a systematic review","volume":"5","author":"Allen","year":"2017","journal-title":"Lancet Glob. Health"},{"issue":"1","key":"10.1016\/j.jcpo.2026.100708_bib26","doi-asserted-by":"crossref","first-page":"9993","DOI":"10.1038\/s41467-024-54444-2","article-title":"An umbrella review of socioeconomic status and cancer","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100708_bib27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.lungcan.2011.01.009","article-title":"Reducing inequalities in lung cancer incidence through smoking policies","volume":"73","author":"Soerjomataram","year":"2011","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.jcpo.2026.100708_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.46234\/ccdcw2025.052","article-title":"Cervical cancer screening rates among Chinese women \u2014 China, 2023\u20132024","volume":"7","author":"Zhang","year":"2025","journal-title":"China CDC Wkly."},{"key":"10.1016\/j.jcpo.2026.100708_bib29","series-title":"Estrat\u00e9gia Nacional de Luta contra o Cancro, horizonte 2030","author":"Di\u00e1rio da Rep\u00fablica","year":"2023"},{"issue":"12","key":"10.1016\/j.jcpo.2026.100708_bib30","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S1470-2045(17)30861-6","article-title":"European position statement on lung cancer screening","volume":"18","author":"Oudkerk","year":"2017","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100708_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41571-020-00432-6","article-title":"Lung cancer LDCT screening and mortality reduction \u2014 evidence, pitfalls and future perspectives","volume":"18","author":"Oudkerk","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jcpo.2026.100708_bib32","series-title":"Lung Cancer Screening","author":"National Health Service","year":"2023"},{"key":"10.1016\/j.jcpo.2026.100708_bib33","series-title":"The Opportunity for Rapid Access to Cytologists in the Diagnosis of Lung Cancer at the Karolinska Institute","author":"Lung Cancer Policy Network","year":"2023"},{"key":"10.1016\/j.jcpo.2026.100708_bib34","series-title":"Kapacitet f\u00f6r lungcancerscreening i\u00a0Sverige: Utmaningar och l\u00f6sningar (IHE Rapport\u00a02024:13) [Policy Report Summary]","author":"Swedish Institute for Health Economics","year":"2024"},{"issue":"7","key":"10.1016\/j.jcpo.2026.100708_bib35","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","article-title":"Cancer biomarkers: emerging trends and clinical implications for personalized treatment","volume":"187","author":"Passaro","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jcpo.2026.100708_bib36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/jpm12010072","article-title":"Identifying the steps required to effectively implement next-generation sequencing in oncology at a national level in Europe","volume":"12","author":"Horgan","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.jcpo.2026.100708_bib37","unstructured":"Canadian Strategy for Cancer Control 2019\u20132029, 2019. \u3008https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2019\/06\/Canadian-Strategy-Cancer-Control-2019-2029-EN.pdf\u3009 (last accessed 28th October 2025)."},{"issue":"3","key":"10.1016\/j.jcpo.2026.100708_bib38","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3390\/curroncol31030103","article-title":"Barriers and unequal access to timely molecular testing results: addressing the inequities in cancer care delays across Canada","volume":"31","author":"Snow","year":"2024","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.jcpo.2026.100708_bib39","article-title":"Addressing the need for genetic cancer risk assessment in Mexico: from establishment of a formal program to delivery innovation and expansion","volume":"2","author":"Ch\u00e1varri-Guerra","year":"2024","journal-title":"Genet. Med. Open"},{"key":"10.1016\/j.jcpo.2026.100708_bib40","unstructured":"Programa De Acci\u00f3n Espec\u00edfico Prevenci\u00f3n Y Control Del C\u00e1ncer 2021\u20132024, 2021. \u3008https:\/\/www.gob.mx\/salud\/documentos\/programa-de-accion-especificao\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib41","series-title":"Unlocking the Potential of Precision Medicine in Europe: Improving Cancer Care through Broader Access to Quality Biomarker Testing","author":"European Federation of Pharmaceutical Industries and Associations, International Quality Network for Pathology, & European Cancer Patient Coalition","year":"2021"},{"key":"10.1016\/j.jcpo.2026.100708_bib42","series-title":"Esri Health GIS Conference, Cambridge, USA","article-title":"Spatial accessibility to cancer care facilities in Saudi Arabia","author":"Al-Ahmadi","year":"2013"},{"issue":"3","key":"10.1016\/j.jcpo.2026.100708_bib43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/bju.15495","article-title":"The cancer multidisciplinary team meeting: in need of change? History, challenges and future perspectives","volume":"128","author":"Winters","year":"2021","journal-title":"BJU Int."},{"key":"10.1016\/j.jcpo.2026.100708_bib44","series-title":"Krebsrahmenprogramm \u00d6sterreich","author":"Austria","year":"2014"},{"key":"10.1016\/j.jcpo.2026.100708_bib45","series-title":"Silos in Healthcare are Bad for Us. Here\u2019s the Cure","author":"Sperling","year":"2020"},{"key":"10.1016\/j.jcpo.2026.100708_bib46","unstructured":"Pol\u00edtica Nacional para a Preven\u00e7\u00e3o e Controle do C\u00e2ncer, 2013. \u3008https:\/\/www.iccp-portal.org\/sites\/default\/files\/plans\/BRA_B5_Politica_cancer.pdf\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib47","article-title":"Barriers and facilitators to provide multidisciplinary care for breast cancer patients in five Latin American countries: a descriptive-interpretative qualitative study","volume":"11","author":"Barrios","year":"2022","journal-title":"Lancet Reg. Health Am."},{"issue":"4","key":"10.1016\/j.jcpo.2026.100708_bib48","first-page":"1","article-title":"Global survey of clinical oncology workforce","author":"Mathew","year":"2018","journal-title":"J. Glob. Oncol."},{"key":"10.1016\/j.jcpo.2026.100708_bib49","unstructured":"NHS England Cancer Programme progress update \u2013 Spring 2024, NHS England, 2024. \u3008https:\/\/www.england.nhs.uk\/long-read\/nhs-england-cancer-programme-progress-update-spring-2024\/\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib50","unstructured":"Cancer action plan: progress report 1 \u2013 June 2023 to March 2024, 2024. \u3008https:\/\/www.gov.scot\/publications\/cancer-action-plan-progress-report-1-june-2023-march-2024\/\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib51","unstructured":"Clinical Oncology Workforce Census 2023, 2023. \u3008https:\/\/www.rcr.ac.uk\/media\/j5jmhpju\/rcr-census-clinical-oncology-workforce-census-2023.pdf\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib52","article-title":"Addressing the oncologist shortage in Latin America: insights from a survey of medical oncology fellowship programs","volume":"11","author":"Zegarra-L\u00f3pez","year":"2025","journal-title":"JCO Glob. Oncol."},{"key":"10.1016\/j.jcpo.2026.100708_bib53","unstructured":"What is a Cancer Registry?, National Cancer Institute: Surveillance, Epidemiology and End Results Program, n.d. \u3008https:\/\/seer.cancer.gov\/registries\/cancer_registry\/\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib54","unstructured":"1 in 2 countries unprepared to prevent and manage cancers, WHO, 2013. \u3008https:\/\/www.who.int\/news\/item\/01-02-2013-1-in-2-countries-unprepared-to-prevent-and-manage-cancers\u3009 (last accessed 28th October 2025)."},{"issue":"10476","key":"10.1016\/j.jcpo.2026.100708_bib55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(25)00189-8","article-title":"Cancer registries bedrock global cancer care","volume":"405","author":"The Lancet","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jcpo.2026.100708_bib56","series-title":"Country Cancer Profile 2025: The Netherlands","author":"OECD","year":"2025"},{"issue":"9","key":"10.1016\/j.jcpo.2026.100708_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-015700","article-title":"Disparities in availability of new cancer drugs worldwide: 1990\u20132022","volume":"9","author":"Li","year":"2024","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.jcpo.2026.100708_bib58","series-title":"FIFARMA Patient W.A.I.T. Indicator 2024 \u2014 Latin America","author":"FIFARMA","year":"2024"},{"key":"10.1016\/j.jcpo.2026.100708_bib59","series-title":"EFPIA Patients W.A.I.T. Indicator 2024 Survey","author":"EFPIA","year":"2025"},{"issue":"23","key":"10.1016\/j.jcpo.2026.100708_bib60","doi-asserted-by":"crossref","first-page":"E815","DOI":"10.1503\/cmaj.230339","article-title":"Is Canada missing out? An assessment of drugs approved internationally between 2016 and 2020 and not submitted for Health Canada review","volume":"195","author":"Gaudette","year":"2023","journal-title":"CMAJ Can. Med. Assoc. J. = J. de l\u2032Assoc. Med. Can."},{"issue":"1","key":"10.1016\/j.jcpo.2026.100708_bib61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40487-022-00187-3","article-title":"Estimating the impact of delayed access to oncology drugs on patient outcomes in Canada","volume":"10","author":"Vanderpuye-Orgle","year":"2022","journal-title":"Oncol. Ther."},{"issue":"1","key":"10.1016\/j.jcpo.2026.100708_bib62","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1186\/s12885-022-10243-w","article-title":"Paradoxes of breast cancer incidence and mortality in two corners of Europe","volume":"22","author":"Roginski","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jcpo.2026.100708_bib63","series-title":"Germany Again to Reform Drug Pricing and Reimbursement Laws \u2013 With \u201cConfidential Reimbursements Prices\u201d That Impede International Reference Pricing","author":"Koyuncu","year":"2024"},{"issue":"10","key":"10.1016\/j.jcpo.2026.100708_bib64","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S1470-2045(21)00463-0","article-title":"Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey","volume":"22","author":"Fundytus","year":"2021","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.jcpo.2026.100708_bib65","doi-asserted-by":"crossref","DOI":"10.1017\/S0266462324004720","article-title":"The role and value of real-world evidence in health technology decision-making in France, Germany, Italy, Spain, and the UK: insights on external control arms","volume":"41","author":"Vidalis","year":"2025","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"10.1016\/j.jcpo.2026.100708_bib66","series-title":"Guide on Real-world Evidence Provided by EMA to Support Regulatory Decision-making","author":"European Medicines Agency","year":"2024"},{"key":"10.1016\/j.jcpo.2026.100708_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.pec.2023.107838","article-title":"Patient complaints about communication in cancer care settings: hidden between the lines","volume":"114","author":"Hult","year":"2023","journal-title":"Patient Educ. Couns."},{"key":"10.1016\/j.jcpo.2026.100708_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcpo.2023.100465","article-title":"Implementing the European code of cancer practice in rural settings","volume":"39","author":"Nelson","year":"2024","journal-title":"J. Cancer Policy"},{"key":"10.1016\/j.jcpo.2026.100708_bib69","series-title":"Notice on Issuing the Implementation Plan for the Healthy China Action\u2014Cancer Prevention and Control Action (2023\u20132030)","author":"Department of Medical Emergency Response","year":"2023"},{"issue":"1","key":"10.1016\/j.jcpo.2026.100708_bib70","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(22)00540-X","article-title":"European Groundshot\u2014addressing Europe\u2019s cancer research challenges: a Lancet Oncology Commission","volume":"24","author":"Lawler","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcpo.2026.100708_bib71","series-title":"Cancer Research Investment in Ireland (2019\u20132022)","author":"Mizzoni","year":"2024"},{"key":"10.1016\/j.jcpo.2026.100708_bib72","series-title":"All-Island Cancer Research Landscape Report (2019\u20132024)","author":"Srinivas","year":"2025"},{"key":"10.1016\/j.jcpo.2026.100708_bib73","series-title":"New Cancer Research Strategic Framework for Northern Ireland","author":"Department of Health","year":"2025"},{"key":"10.1016\/j.jcpo.2026.100708_bib74","series-title":"The Personalized Medicine Report: Opportunity, Challenges, and the Future","author":"Personalized Medicine Coalition","year":"2020"},{"key":"10.1016\/j.jcpo.2026.100708_bib75","series-title":"EU Country Cancer Profile 2025: France","author":"OECD, & European Commission","year":"2025"},{"issue":"2","key":"10.1016\/j.jcpo.2026.100708_bib76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4103\/jmp.jmp_21_24","article-title":"Analyzing global cancer control: progress of national cancer control programs through composite indicators and regression modeling","volume":"49","author":"Chauhan","year":"2024","journal-title":"J. Med. Phys."},{"issue":"11","key":"10.1016\/j.jcpo.2026.100708_bib77","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1158\/1055-9965.EPI-14-0472","article-title":"Implementation science in cancer prevention and control: a framework for research and programs in low- and middle-income countries","volume":"23","author":"Sivaram","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.jcpo.2026.100708_bib78","series-title":"The Current Global Landscape of National Cancer Strategies: A New Review by UICC and ICCP","author":"UICC","year":"2024"},{"key":"10.1016\/j.jcpo.2026.100708_bib79","series-title":"Flash Briefing: European Commission Publishes Proposed New EU budget 2028\u20132034","author":"European Cancer Organisation","year":"2025"},{"key":"10.1016\/j.jcpo.2026.100708_bib80","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S2214-109X(21)00116-9","article-title":"Equity as a consideration in National Cancer Control Plans from the American continent: a comparative content analysis","volume":"9","author":"Loggetto","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jcpo.2026.100708_bib81","unstructured":"World Health Organization, Countries and areas by WHO region, n.d. \u3008https:\/\/apps.who.int\/violence-info\/Countries%20and%20areas%20by%20WHO%20region%20-%2012bfe12.pdf\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib82","unstructured":"World Bank, The world by income and region, in: World Development Indicators, n.d. \u3008https:\/\/datatopics.worldbank.org\/world-development-indicators\/the-world-by-income-and-region.html\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib83","series-title":"Age-Standardized Rate (World) per 100,000, Mortality, Both Sexes, in 2022","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.jcpo.2026.100708_bib84","unstructured":"WHO European Observatory, Country overview: Austria, n.d. \u3008https:\/\/Eurohealthobservatory.Who.Int\/Countries\/Austria\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib85","unstructured":"Physicians for a National Health Program, Health care systems \u2013 Four Basic Models, n.d. \u3008https:\/\/www.pnhp.org\/single_payer_resources\/health_care_systems_four_basic_models.php\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib86","doi-asserted-by":"crossref","first-page":"119","DOI":"10.11606\/S1518-8787.2017051000315","article-title":"Public policies on healthcare-associated infections: a Brazil and UK case study","volume":"51","author":"Padoveze","year":"2017","journal-title":"Rev. de Sa\u00faDe. P\u00fablica"},{"issue":"1","key":"10.1016\/j.jcpo.2026.100708_bib87","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s44263-024-00096-9","article-title":"China\u2019s universal medical insurance scheme: progress and perspectives","volume":"2","author":"Zhang","year":"2024","journal-title":"BMC Glob. Public Health"},{"key":"10.1016\/j.jcpo.2026.100708_bib88","unstructured":"WHO European Observatory, Country overview: Germany, n.d. \u3008https:\/\/eurohealthobservatory.who.int\/countries\/germany\u3009 (last accessed 28th October 2025)."},{"key":"10.1016\/j.jcpo.2026.100708_bib89","series-title":"World Health Systems \u2013 Ireland","author":"International Federation of Health Plans","year":"2024"},{"key":"10.1016\/j.jcpo.2026.100708_bib90","series-title":"Health Financing Profile \u2013 Mexico","author":"Class","year":"2014"},{"key":"10.1016\/j.jcpo.2026.100708_bib91","series-title":"International Health Care System Profiles: Netherlands","author":"Tikkanen","year":"2020"},{"issue":"8","key":"10.1016\/j.jcpo.2026.100708_bib92","first-page":"1","article-title":"Norway: health system review","volume":"15","author":"Ringard","year":"2013","journal-title":"Health Syst. Transit."},{"key":"10.1016\/j.jcpo.2026.100708_bib93","series-title":"Portugal: Health System Summary","author":"WHO European Observatory","year":"2025"},{"issue":"24","key":"10.1016\/j.jcpo.2026.100708_bib94","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.3390\/healthcare12242544","article-title":"Healthcare financing in Saudi Arabia: a comprehensive review","volume":"12","author":"Nair","year":"2024","journal-title":"Healthcare"},{"key":"10.1016\/j.jcpo.2026.100708_bib95","series-title":"Spain: Health System Summary","author":"WHO European Observatory","year":"2024"},{"key":"10.1016\/j.jcpo.2026.100708_bib96","unstructured":"European Observatory on Health Systems and Policies & World Health Organization Regional Office for Europe, T\u00fcrkiye. in: European Health Information Gatewa\/Country Profiles, n.d. \u3008https:\/\/eurohealthobservatory.who.int\/countries\/turkiye\u3009 (last accessed 28th October 2025)."}],"container-title":["Journal of Cancer Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538326000081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538326000081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T06:37:59Z","timestamp":1773988679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213538326000081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":96,"alternative-id":["S2213538326000081"],"URL":"https:\/\/doi.org\/10.1016\/j.jcpo.2026.100708","relation":{},"ISSN":["2213-5383"],"issn-type":[{"value":"2213-5383","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis and recommendations to improve national cancer control plans and policies informed by a 20 country analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cancer Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcpo.2026.100708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100708"}}